##gff-version 3
##sequence-region Q01167 1 660
Q01167	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:20068231;Dbxref=PMID:19413330,PMID:20068231	
Q01167	UniProtKB	Chain	2	660	.	.	.	ID=PRO_0000091858;Note=Forkhead box protein K2	
Q01167	UniProtKB	Domain	54	128	.	.	.	Note=FHA;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00086	
Q01167	UniProtKB	DNA binding	258	353	.	.	.	Note=Fork-head;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00089	
Q01167	UniProtKB	Region	129	171	.	.	.	Note=Required for interaction with DVL2 and SUDS3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Region	300	318	.	.	.	Note=DNA-binding%3B major groove	
Q01167	UniProtKB	Region	328	332	.	.	.	Note=DNA-binding%3B minor groove	
Q01167	UniProtKB	Region	348	353	.	.	.	Note=DNA-binding%3B minor groove	
Q01167	UniProtKB	Compositional bias	10	93	.	.	.	Note=Gly-rich	
Q01167	UniProtKB	Metal binding	310	310	.	.	.	Note=Magnesium%3B via carbonyl oxygen	
Q01167	UniProtKB	Metal binding	311	311	.	.	.	Note=Magnesium%3B via carbonyl oxygen	
Q01167	UniProtKB	Metal binding	313	313	.	.	.	Note=Magnesium%3B via carbonyl oxygen	
Q01167	UniProtKB	Metal binding	316	316	.	.	.	Note=Magnesium%3B via carbonyl oxygen	
Q01167	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:20068231;Dbxref=PMID:19413330,PMID:20068231	
Q01167	UniProtKB	Modified residue	30	30	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q01167	UniProtKB	Modified residue	144	144	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q01167	UniProtKB	Modified residue	239	239	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17525332,ECO:0000244|PubMed:23186163;Dbxref=PMID:17525332,PMID:23186163	
Q01167	UniProtKB	Modified residue	373	373	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q3UCQ1	
Q01167	UniProtKB	Modified residue	398	398	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:19690332,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q01167	UniProtKB	Modified residue	424	424	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
Q01167	UniProtKB	Modified residue	428	428	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18220336,PMID:19690332,PMID:20068231,PMID:23186163	
Q01167	UniProtKB	Modified residue	599	599	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q3UCQ1	
Q01167	UniProtKB	Cross-link	161	161	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q01167	UniProtKB	Cross-link	164	164	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q01167	UniProtKB	Cross-link	527	527	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
Q01167	UniProtKB	Cross-link	633	633	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q01167	UniProtKB	Alternative sequence	304	328	.	.	.	ID=VSP_001560;Note=In isoform 3. NSIRHNLSLNRYFIKVPRSQEEPGK->RGESFAHVGNTRIRIGLPAHKAPQR;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q01167	UniProtKB	Alternative sequence	329	660	.	.	.	ID=VSP_001561;Note=In isoform 3. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q01167	UniProtKB	Alternative sequence	596	660	.	.	.	ID=VSP_001559;Note=In isoform 2. AAASPLHMLATHASASASLPTKRHNGDQPEQPELKRIKTEDGEGIVIALSVDTPPAAVREKGVQN->GPLGLRRPPCASSDWSCLS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:1339390;Dbxref=PMID:1339390	
Q01167	UniProtKB	Mutagenesis	129	129	.	.	.	Note=No effect on interaction with DVL2. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	130	130	.	.	.	Note=No effect on interaction with DVL2. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	131	131	.	.	.	Note=No effect on interaction with DVL2. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	133	133	.	.	.	Note=No effect on interaction with DVL2. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	136	136	.	.	.	Note=No effect on interaction with DVL2. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Abolishes interaction with DVL2 and SUDS3 as well as DVL2 nuclear translocation. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	138	138	.	.	.	Note=No effect on interaction with DVL2. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	141	141	.	.	.	Note=No effect on interaction with DVL2. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	142	142	.	.	.	Note=No effect on interaction with DVL2. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Abolishes interaction with DVL2 and SUDS3 as well as DVL2 nuclear translocation. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Highly reduces interaction with DVL2. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	147	147	.	.	.	Note=No effect on interaction with DVL2. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	148	148	.	.	.	Note=No effect on interaction with DVL2. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	150	150	.	.	.	Note=No effect on interaction with DVL2. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	151	151	.	.	.	Note=No effect on interaction with DVL2. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	152	152	.	.	.	Note=No effect on interaction with DVL2. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	154	154	.	.	.	Note=Abolishes interaction with DVL2 and SUDS3 as well as DVL2 nuclear translocation. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	155	155	.	.	.	Note=No effect on interaction with DVL2. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	157	157	.	.	.	Note=No effect on interaction with DVL2. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	258	258	.	.	.	Note=Decreases DNA-binding to 40%25. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16624804;Dbxref=PMID:16624804	
Q01167	UniProtKB	Mutagenesis	300	300	.	.	.	Note=Decreases DNA-binding to 20%25. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16624804;Dbxref=PMID:16624804	
Q01167	UniProtKB	Mutagenesis	305	305	.	.	.	Note=Decreases DNA-binding to 70%25. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16624804;Dbxref=PMID:16624804	
Q01167	UniProtKB	Mutagenesis	307	307	.	.	.	Note=Abolishes DNA-binding. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16624804;Dbxref=PMID:16624804	
Q01167	UniProtKB	Mutagenesis	308	308	.	.	.	Note=No effect on interaction with DVL2. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25805136;Dbxref=PMID:25805136	
Q01167	UniProtKB	Mutagenesis	328	328	.	.	.	Note=Decreases DNA-binding to 25%25. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16624804;Dbxref=PMID:16624804	
Q01167	UniProtKB	Sequence conflict	3	120	.	.	.	Note=AAAAALSGAGTPPAGGGAGGGGAGGGGSPPGGWAVARLEGREFEYLMKKRSVTIGRNSSQGSVDVSMGHSSFISRRHLEIFTPPGGGGHGGAAPELPPAQPRPDAGGDFYLRCLGKNG->Q;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q01167	UniProtKB	Helix	263	272	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2C6Y	
Q01167	UniProtKB	Beta strand	277	279	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JXS	
Q01167	UniProtKB	Helix	281	291	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2C6Y	
Q01167	UniProtKB	Beta strand	295	298	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JXS	
Q01167	UniProtKB	Helix	300	312	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2C6Y	
Q01167	UniProtKB	Beta strand	316	319	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2C6Y	
Q01167	UniProtKB	Beta strand	324	329	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JXS	
Q01167	UniProtKB	Beta strand	331	334	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2C6Y	
Q01167	UniProtKB	Helix	336	346	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2C6Y	
